SPPI Insider Trading Activity and SEC Form 4 Filings
SPPI insider trading summary
No open-market insider purchases or sales of Spectrum Pharmaceuticals Inc (SPPI) have been reported on SEC Form 4 in the past 12 months.
Latest SPPI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 26, 2023 | Nora Brennan | CFO | Sell | $35K (32,387 @ $1.10) |
| Mar 15, 2023 | Thomas J Riga | CEO & President | Sell | $25K (31,381 @ $0.80) |
| Mar 15, 2023 | Keith M McGahan | Chief Legal Officer | Sell | $22K (27,197 @ $0.80) |
| Mar 14, 2023 | Keith M McGahan | Chief Legal Officer | Sell | $13K (15,733 @ $0.82) |
| Mar 14, 2023 | Thomas J Riga | CEO & President | Sell | $15K (18,153 @ $0.82) |
| Feb 23, 2023 | Keith M McGahan | Chief Legal Officer | Sell | $14K (18,385 @ $0.77) |
| Feb 22, 2023 | Keith M McGahan | Chief Legal Officer | Sell | $9K (11,990 @ $0.76) |
| Feb 22, 2023 | Thomas J Riga | CEO & President | Sell | $11K (14,607 @ $0.76) |
| Feb 22, 2023 | Thomas J Riga | CEO & President | Sell | $17K (22,402 @ $0.77) |
| Jan 31, 2023 | Keith M McGahan | Chief Legal Officer | Sell | $25K (41,014 @ $0.62) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.